← Leaderboards
Jasper R Chen
University Of Tx Md Anderson Can Ctr
$226,065
Attributed
$226,065
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.2K · FY2020–24$50K$37.5K$25K$12.5K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$226,065 · 1
By mechanism
F30$226,065 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Dihua Yu$18,443,603
- Li Ma$7,923,692
- Wen-Hao Hsu$277,735
- Khandan Keyomarsi$13,000,468
- Y. Alan Wang$3,748,710
Others in their field
Other Emerging Leaders on “Cell Survival”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,031,836
- Amit Singal · Ut Southwestern Medical Center$9,030,809
- Balasubramani K Goundappa · University Of Pittsburgh At Pittsburgh$8,538,627
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$7,954,130
- Terry Roemer · Prokaryotics, Inc.$7,569,097
Research focus
Cell SurvivalAffectAllelesCellsAnxa5 GeneApoptosisApoptoticBinding SitesAneuploidyCell ProliferationCancer CellCancer GenomeCancer GenomicsCancer SurvivalCancer TherapyCancer TypeCareerCasp3 GeneCategoriesCell CycleBromodeoxyuridineAcetylationCell LineCell Type
Grant awards (5)
Exploration of long non-coding RNAs as synthetic essential targets in Pten-deficient cancers$47,192
F30 · FY2024 · CA · contact PI
Exploration of long non-coding RNAs as synthetic essential targets in Pten-deficient cancers$45,912
F30 · FY2023 · CA · contact PI
Exploration of long non-coding RNAs as synthetic essential targets in Pten-deficient cancers$44,970
F30 · FY2022 · CA · contact PI
Exploration of long non-coding RNAs as synthetic essential targets in Pten-deficient cancers$44,254
F30 · FY2021 · CA · contact PI
Exploration of long non-coding RNAs as synthetic essential targets in Pten-deficient cancers$43,737
F30 · FY2020 · CA · contact PI